Artificial intelligence continues deep integration into biotech workflows and clinical research. Advarra launched an AI and data-driven protocol optimization tool, Study Design, leveraging historic trial data to streamline study designs and reduce operational burdens. Concurrently, finance functions in biopharma adopt embedded AI for accounts automation and error reduction, emphasizing governance concerns. These developments signal a move towards smarter, efficient drug development processes and financial operations, harnessing AI capabilities embedded in existing ecosystems rather than standalone implementations.